Invention Grant
- Patent Title: CD20 scFv-ELPs methods and therapeutics
-
Application No.: US16254531Application Date: 2019-01-22
-
Publication No.: US10961317B2Publication Date: 2021-03-30
- Inventor: Alan L. Epstein , John Andrew MacKay , Peisheng Hu , Suhaas Aluri
- Applicant: University of Southern California
- Applicant Address: US CA Los Angeles
- Assignee: University of Southern California
- Current Assignee: University of Southern California
- Current Assignee Address: US CA Los Angeles
- Agency: Foley & Lardner LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/78 ; A61K47/69 ; A61K47/68 ; A61K47/64 ; A61K38/00 ; A61K9/107 ; A61K9/51 ; A61K39/00 ; A61K48/00
Abstract:
Disclosed herein are recombinant polypeptides comprising an elastin-like peptide (ELP) and a scFv, or a biological equivalent of the scFv. Also disclosed are compositions containing scFv-ELP polypeptides and methods of use.
Public/Granted literature
- US20200079868A1 CD20 scFv-ELPs METHODS AND THERAPEUTICS Public/Granted day:2020-03-12
Information query
